國金證券(600109.SH):旗下的國金證券(香港)有限公司正在籌備申請虛擬資產相關交易牌照
格隆匯7月7日丨國金證券(600109.SH)在互動平臺表示,公司旗下的國金證券(香港)有限公司正在籌備申請虛擬資產相關交易牌照,並與國際及香港地區具有豐富經驗的相關機構就該事項進行了多次接觸,後續將積極推進具體申請事宜。國金證券(香港)有限公司持有香港證監會頒發的業務牌照包括:第1號:證券交易;第2號:期貨合約交易;第4號:就證券提供意見;第6號:就機構融資提供意見;第9號:提供資產管理。公司將持續加大對境外業務的積極拓展,通過發揮香港子公司擁有1、2、4、6、9號牌照齊全的優勢,實現了高效的業務協同,爲公司的境外客戶提供較爲完整的融資和投資服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.